97.44
price up icon0.93%   0.90
pre-market  プレマーケット:  97.64   0.20   +0.21%
loading
前日終値:
$96.54
開ける:
$96.98
24時間の取引高:
10.25M
Relative Volume:
1.16
時価総額:
$248.54B
収益:
$63.17B
当期純損益:
$12.15B
株価収益率:
54.13
EPS:
1.8
ネットキャッシュフロー:
$14.84B
1週間 パフォーマンス:
-1.08%
1か月 パフォーマンス:
-10.36%
6か月 パフォーマンス:
-25.61%
1年 パフォーマンス:
-5.10%
1日の値動き範囲:
Value
$96.66
$98.84
1週間の範囲:
Value
$94.48
$99.40
52週間の値動き範囲:
Value
$94.48
$134.63

Merck Co Inc Stock (MRK) Company Profile

Name
名前
Merck Co Inc
Name
セクター
Healthcare (1193)
Name
電話
908-740-4000
Name
住所
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Name
職員
72,000
Name
Twitter
@Merck
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
MRK's Discussions on Twitter

MRK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MRK 97.44 248.54B 63.17B 12.15B 14.84B 1.80
LLY 753.41 693.54B 40.86B 8.37B -2.28B 5.4193
NVO 105.27 465.74B 39.36B 13.79B 9.83B 2.4077
JNJ 153.11 353.35B 87.70B 14.68B 19.03B 13.47
ABBV 167.76 294.70B 55.53B 5.12B 15.62B 3.65

Merck Co Inc Stock (MRK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-17 開始されました Bernstein Mkt Perform
2024-03-11 ダウングレード Societe Generale Hold → Sell
2024-01-04 アップグレード TD Cowen Market Perform → Outperform
2023-11-09 開始されました Deutsche Bank Buy
2023-10-27 アップグレード BMO Capital Markets Market Perform → Outperform
2023-10-20 アップグレード UBS Neutral → Buy
2023-07-14 開始されました HSBC Securities Hold
2023-04-13 アップグレード Citigroup Neutral → Buy
2023-03-28 ダウングレード Societe Generale Buy → Hold
2023-03-13 ダウングレード Wells Fargo Overweight → Equal Weight
2023-03-06 開始されました Jefferies Buy
2023-02-22 アップグレード Wolfe Research Peer Perform → Outperform
2023-01-04 アップグレード BofA Securities Neutral → Buy
2022-11-18 開始されました Credit Suisse Outperform
2022-10-10 アップグレード Guggenheim Neutral → Buy
2022-09-14 アップグレード Berenberg Hold → Buy
2022-07-06 アップグレード Daiwa Securities Neutral → Buy
2022-06-06 再開されました SVB Leerink Outperform
2022-04-06 再開されました Morgan Stanley Equal-Weight
2021-12-17 開始されました Goldman Buy
2021-12-16 開始されました Daiwa Securities Neutral
2021-12-13 ダウングレード UBS Buy → Neutral
2021-12-09 開始されました Wells Fargo Overweight
2021-12-07 ダウングレード Guggenheim Buy → Neutral
2021-11-29 ダウングレード Citigroup Buy → Neutral
2021-11-19 開始されました BMO Capital Markets Market Perform
2021-11-01 アップグレード Argus Hold → Buy
2021-09-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-07-27 再開されました Truist Buy
2021-05-20 ダウングレード Argus Buy → Hold
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2020-11-10 再開されました Bernstein Outperform
2020-09-29 開始されました Berenberg Hold
2020-08-03 アップグレード Goldman Neutral → Buy
2020-06-12 ダウングレード Wolfe Research Outperform → Peer Perform
2020-02-27 開始されました Barclays Overweight
2020-01-07 開始されました RBC Capital Mkts Sector Perform
2019-10-17 再開されました BofA/Merrill Neutral
2019-08-16 開始されました SVB Leerink Outperform
2019-07-03 開始されました Mizuho Buy
2019-05-28 開始されました Goldman Neutral
2019-05-13 アップグレード Atlantic Equities Neutral → Overweight
2018-10-16 繰り返されました Citigroup Buy
2018-10-09 再開されました Guggenheim Buy
2018-04-23 アップグレード Goldman Neutral → Buy
2018-04-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2018-04-05 アップグレード Barclays Equal Weight → Overweight
2018-03-12 アップグレード Leerink Partners Mkt Perform → Outperform
2018-02-14 繰り返されました Leerink Partners Mkt Perform
2018-02-07 繰り返されました Morgan Stanley Equal-Weight
2018-01-16 アップグレード SunTrust Hold → Buy
すべてを表示

Merck Co Inc (MRK) 最新ニュース

pulisher
06:32 AM

Citizens Financial Group Inc. RI Has $27.79 Million Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

06:32 AM
pulisher
05:56 AM

Ontario Teachers Pension Plan Board Sells 7,664 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

05:56 AM
pulisher
05:31 AM

Jennison Associates LLC Sells 728,756 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

05:31 AM
pulisher
Nov 20, 2024

Merck Foundation Commits $17M to Transform Cardiac Care Access in Underserved Communities | MRK Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio - Insider Monkey

Nov 20, 2024
pulisher
Nov 20, 2024

Payden & Rygel Grows Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Moran Wealth Management LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Grandfield & Dodd LLC - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Connor Clark & Lunn Investment Management Ltd. Sells 792,148 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Commerce Bank Buys 29,422 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Prospera Private Wealth LLC Buys 12,781 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Merck & Co., Inc. (NYSE:MRK) Stake Cut by Northwest Bancshares Inc. - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Strategy Asset Managers LLC Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Quest Partners LLC Has $1.18 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Merck says Keytruda injection on par with approved IV version in trial - Reuters

Nov 19, 2024
pulisher
Nov 19, 2024

Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch

Nov 19, 2024
pulisher
Nov 19, 2024

Merck & Co.’s Subcutaneous Keytruda Matches I.V. - Scrip

Nov 19, 2024
pulisher
Nov 19, 2024

Merck & Co., Inc. (NYSE:MRK) Raises Dividend to $0.81 Per Share - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Merck & Co., Inc. (NYSE:MRK) Shares Down 0.1%Here's Why - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Merck readies new Keytruda version ahead of major regulatory headwinds - Seeking Alpha

Nov 19, 2024
pulisher
Nov 19, 2024

Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Merck & Co. Raises Quarterly Dividend by 5.2% - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Merck Increases Quarterly Dividend to $0.81 Per Share, Payable Jan. 8 to Shareholders of Record Dec. 16 - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Merck Declares $0.81 Per Share Q1 2025 Dividend, Sets January Payment Date | MRK Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

New Millennium Group LLC Has $1.27 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

PNC Financial Services Group Inc. Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

B. Metzler seel. Sohn & Co. Holding AG Makes New $42.43 Million Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Merck: success of a subcutaneous version of Keytruda - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Fifth Third Wealth Advisors LLC Buys 34,312 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Prospera Financial Services Inc Purchases 9,387 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Merck & Co., Inc. (NYSE:MRK) Stock Holdings Boosted by Smead Capital Management Inc. - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Meeder Asset Management Inc. - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Merck stock gains on injectable Keytruda trial win (MRK:NYSE) - Seeking Alpha

Nov 19, 2024
pulisher
Nov 19, 2024

Pathstone Holdings LLC Sells 7,059 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Belmont Capital LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’ - Insider Monkey

Nov 18, 2024
pulisher
Nov 18, 2024

Merck & Co. Inc. stock rises Monday, still underperforms market - MarketWatch

Nov 18, 2024
pulisher
Nov 18, 2024

Merck & Co., Inc. (NYSE:MRK) Trading Down 0.6%What's Next? - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Stocks Flash: Biggest Recent Disappointment (Merck & Co Inc., MRK) and Biggest Bright Spot (Dell Technologies Inc, DELL) - Elliott Wave International

Nov 18, 2024
pulisher
Nov 18, 2024

Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now? - Insider Monkey

Nov 18, 2024
pulisher
Nov 18, 2024

Braun Stacey Associates Inc. Sells 7,853 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

AMG National Trust Bank Sells 5,505 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Aljian Capital Management LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Merck & Co., Inc. (NYSE:MRK) Shares Sold by TrinityPoint Wealth LLC - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Swiss National Bank Has $853.74 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

Thrivent Financial for Lutherans Has $208.65 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

Concord Asset Management LLC VA Has $5.08 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

Mutual of America Capital Management LLC Decreases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Mizuho Securities USA LLC - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Merck & Co., Inc. (NYSE:MRK) Stock Holdings Decreased by Natixis Advisors LLC - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Kentucky Retirement Systems Insurance Trust Fund Lowers Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Nov 16, 2024

Merck Co Inc (MRK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general NVS
$103.09
price down icon 0.17%
$167.76
price up icon 0.71%
$287.87
price up icon 2.83%
drug_manufacturers_general JNJ
$153.11
price up icon 0.07%
drug_manufacturers_general PFE
$24.94
price down icon 0.64%
大文字化:     |  ボリューム (24 時間):